An international study showed that the highest 5-year OS rates were observed in patients with primary cutaneous ALCL (90%) and ALK+ ALCL (70%), while poor 5-year OS rates were found for PTCL-NOS and AITL (both 32%) [6]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.